Alnylam Pharmaceuticals I... (ALNY)
Alnylam Pharmaceuticals Max Pain By Strike
ALNY trades at $452, 25.6% above the near-term max pain of $360 expiring Sep 19, 2025 (12 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is stable across expirations ($310-$460), indicating stable market expectations. Key magnetic zone at 330 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Alnylam Pharmaceuticals Max Pain By Expiry
Max pain for ALNY shows stable levels around 367.50, reflecting balanced market expectations. The 41% spread signals divergent expectations across timeframes. Most levels below 452 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 360 | -92.00 (-20.35%) |
| Oct 17, 2025 | 450 | -2.00 (-0.44%) |
| Dec 19, 2025 | 330 | -122.00 (-26.99%) |
| Jan 16, 2026 | 350 | -102.00 (-22.57%) |
| Mar 20, 2026 | 350 | -102.00 (-22.57%) |
| Jun 18, 2026 | 460 | 8.00 (1.77%) |
| Jul 17, 2026 | 330 | -122.00 (-26.99%) |
| Jan 15, 2027 | 310 | -142.00 (-31.42%) |